CCR7 and neoplasm: Armoured CAR T cells expressing CCL19, a ligand for CCR7 which attracts both T and DC cells, alongside IL-7, was able to increase DC and T cell infiltration and colocalisation in tumours, achieving complete regression in some murine models and significant growth repression in others [214].